Complimentary
Digital Subscription

sp2 Fulfills the needs of the global pharmaceutical and biotechnology community with its highly regarded editorial coverage of industry news and business and technological developments from drug discovery through to scale-up and commercialisation.

Detailed Description

-> sp2 is complimentary to qualified professionals.
-> Geographic Eligibility: USA, Canada, Selected International
-> The publisher determines qualification and reserves the right to limit the number of free subscriptions.
sp2

Complete and verifiable information is required in order to qualify for this Digital Subscription.

First Name:
Last Name:
  Job Title:
  Company Name:
  Business Email:
Phone:
Fax:
Division/Mail Stop:
Street Address:
City:
State/Province:
Postal/ZIP Code:
  Country:

Yes, please auto-fill my contact information for other qualification forms.
 
  What is the approximate number of employees in your company?

1. Do you wish to receive a FREE digital subscription to sp2? Yes     No
2. What is your Job Function?
Please Specify for Other:
3. Type of Business/Industry?
Please Specify for Other:
4. For the publisher's audit purposes, they need you to answer a personal identification question as follows: What are the last two digits of your date of birth?
5. Fields in which you work? (select all that apply)  
ADME/Toxicology Medicinal Chemistry
Assay Development Microbiology
Biochemistry Molecular Biology
Cell Biology Molecular Modeling
Combinatorial Chemistry Organic Chemistry
Computational Chemistry Proteomics
Contract Manufacture Process Development
Contract Research Scale-up
Custom Synthesis Virology
Genomics Other
High Throughput Screening
Please Specify for Other:
Informatics

  Would you like to receive EMAIL notices of other print or online publications, and other relevant offers from TradePub.com? Yes     No
  Sign up for special offer alerts from select partners featuring the latest products and services you are interested in. Yes     No
Related FREE Offers from TradePub.com: Check those you wish to receive.
I wish to receive a FREE subscription to Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, from bench to business, was introduced in 1981 as the first biotechnology trade publication. Now in its 27th year, GEN retains its position as the most widely read biotechnology publication around the globe. Published 21 times a year, GEN's unique news and technology content focus includes the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drug and biomarker discovery, bioprocessing, clinical research, molecular diagnostics, and biobusiness. Note: Offer Valid for Selected International.
Email Notifications: By subscribing to Genetic Engineering & Biotechnology News, you agree to receive GEN promotional materials by email. You may opt-out of these emails at any time by clicking on the unsubscribe link in the email or updating your profile on the Genetic Engineering & Biotechnology News website. Your email address is used for GEN promotional purposes only and will not be distributed to other parties.
  Job Function: (select only one)


Please specify for Other.
  Organization: (select only one)


Please specify for Other.
  Technologies: (select all that apply)
Molecular Biology Tissue Engineering
Gene Expression Transgenics
Genomics Bioreactors/Fermentation
Nucleic Acid Isolation/Purification Filtration
Nucleic Acid Sequencing Process Monitoring
Nucleic Acid Synthesis Purification
PCR Separations
Quantitative PCR Analytical/Medicinal Chemistry
RNAi/siRNA ADME/Tox
Transfection Assay Development
Proteomics Drug Delivery
Biomarkers Gene Therapy
Peptides High-throughput Screening
Protein Sequencing Metabolomics
Protein Expression & Purification Protein/Drug Design
Protein-Protein Interaction Analysis Automation/Robotics
Cell/Tissue Culture Chromatography
Cell Based Analysis Electrophoresis
Cell-based Technologies HPLC
Immunology Image Analysis
Microscopy Mass Spectrometry
Monoclonal Antibodies Software/Informatics
Stem Cells
  Area of Focus: (select all that apply)
Drug Discovery Chemicals
Biologicals Supplier/Instrumentation
Manufacturing/Packaging Toxicology
Environmental Pharmaceuticals
Animal Health Contract Manufacturing
Supplier/Reagent Clinical Trials
Molecular Biology Contract Research
Research/Development Agriculture
Bioprocessing/Scale-up Food Processing
Industrial Biotechnology Other
Molecular Diagnostics
  Do you specify, influence, recommend, or buy products and services associated with biotechnology/pharmaceutical/life science research and development?
Yes     No
  In lieu of a signature, Mary Ann Liebert, Inc.'s require a personal identifier. To verify that you submitted this subscription request, what is the state/province where you were born?

I wish to receive a Free subscription to Nature Biotechnology. The science and business of biotechnology. Nature Biotechnology devotes pages specifically to in-depth analysis of issues concerning biotechnology intellectual property case law and policy, together with breaking news on patents. Also included in each issue are key emerging areas such as computational biology and materials science. Note: Offer Valid in the USA, Canada, Selected International.
Nature Publishing Group may wish to keep you informed about their products, services and special offers. Please check this box if you do not wish to receive this information.
Please check here if you would prefer not to receive relevant information from selected companies other than the Nature Publishing Group.
  For verification, what is your shoe size?
  Which of the following best describes your area of specialization? (select only one)


Please specify for Other:
  In which type of institution do you currently work or study? (select only one)


Please specify for Other:
  What is your current position? (select only one)


Please specify for Other:
  Please indicate your most recently-attained professional qualification: (select only one)

c_phv I wish to receive a FREE subscription to PharmaVOICE which provides multiple perspectives on the business challenges, trends, and topics impacting the life-sciences by engaging compelling personalities from diverse industry sectors in a thought-provoking dialog to facilitate and improve business-to-business relationships. Your subscription to PharmaVOICE will also include it's supporting sector-specific VIEW publications. Note: Offer Valid in USA Only.
Prefix: Middle Initial: Degree (i.e.: MBA, MD, PharmD, PhD, RPH, RN, etc)
Yes, I would like to be notified about PharmaVOICE updates and special offers.
Yes, I would like to be notified about special offers from PharmaVOICE partners.
Email Mail Both Email & Mail HTML Plain Text
  Please select the month you were born:
  Which best describes the company you work for?  
Please Specify for Other:
  Which best describes your job function?
Please Specify for Other:

c_cpa I wish to receive a FREE subscription to Contract Pharma. Devoted to pharmaceutical and biopharmaceutical contract services outsourcing, Contract Pharma is a must read for the pharmaceutical/biopharmaceutical industry professional. Note: Offer Valid in the United States Only.
I do not wish to receive third party email promotions, please check here.
  What is your firm's primary business?
Please Specify for Other:
  What is your function?
Please Specify for Other:
  In order to verify your request for this publication, without the availability of a signature Rodman Publishing Corporation's audit bureau requires that Contract Pharma ask a personal identifying question. This information is used solely for the purpose of auditing your request. What is your month of birth?

Security Check: Enter both words below, separated by a space.
 
     

* Note that a valid email and physical mailing address is required to fulfill your request. Please verify that the email and mailing address you provided are accurate before submitting your information.
* The publisher reserves the right to limit the number of complimentary subscriptions and/or reject requests based on information provided.